A real-world retrospective observational study to determine effect of benralizumab on Fractional exhaled nitric oxide and clinical outcomes in patients with severe eosinophilic asthma and high FeNO levels
Latest Information Update: 29 Jun 2021
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 29 Jun 2021 New trial record
- 19 May 2021 Results presented at the 117th International Conference of the American Thoracic Society